InvestorsHub Logo
Followers 339
Posts 19333
Boards Moderated 0
Alias Born 08/25/2007

Re: None

Tuesday, 09/20/2016 9:52:38 AM

Tuesday, September 20, 2016 9:52:38 AM

Post# of 2049
Phase II study of NAFLD/NASH is completed and we look forward to commencing this important study. Based on the good safety data we have on CF102 from our current Phase II trial in liver cancer
http://ih.advfn.com/p.php?pid=nmona&article=72040511

DONT LISTEN TO ME IM CANADIANNNNNNNN

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CANF News